BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 27, 2009
View Archived Issues
Mitomycin C may prevent bladder tumor formation in upper tract transitional cell carcinoma patients
Read More
Pfizer introduces four novel MMP-13 inhibitors as candidates for osteoarthritis treatment
Read More
IMPACT2 shows relief of hereditary angioedema attacks with C1-INH
Read More
Novel P-glycoprotein inhibitor is developed as an oral absorption enhancing agent
Read More
Novel compounds for the treatment of hepatitis C discovered by Bristol-Myers Squibb
Read More
Pfizer presents novel cholesteryl ester transfer protein inhibitors
Read More
Regeneron initiates phase III gout program with Arcalyst
Read More
Phase III ASA-404 trial in lung cancer extended to Japan
Read More
Advancell collaborates with Nobera to develop hand-foot syndrome treatment
Read More
Novel neutrophil elastase inhibitor shows efficacy in rat lung injury model
Read More
Abeille licenses AB-1001 to Prostrakan for North America and Europe
Read More
Cyclopamine analogues developed for cancer treatment
Read More
Emerflu pandemic influenza vaccine approved in Australia
Read More
Exenatide data analysis shows no increased risk of cardiovascular events
Read More
Trubion initiates phase I SBI-087 study in systemic lupus erythematosus
Read More
Roche completes tender offer for Genentech
Read More
RegeneRx presents phase II RGN-137 results in venous stasis
Read More
Neurotech reports phase II NT-501 results in dry AMD
Read More
Neurocrine reports top-line results from phase II elagolix trial in endometriosis
Read More
Novel histone deacetylase inhibitors claimed by Syndax Pharmaceuticals
Read More
Molecular Insight reports detailed phase II data for Zemiva
Read More
Recent Roche patent claims novel Raf kinase B and C inhibitors as antiproliferative agents
Read More
GlycoMimetics completes two phase I studies for GMI-1070
Read More
Novel monoamine reuptake inhibitors emerge from GlaxoSmithKline R&D
Read More
Interim results from phase II EC-145 trial reported by Endocyte
Read More
Acadia and Meiji Seika enter collaboration for procognitive drugs for schizophrenia
Read More